- Home
- Media
- Press Releases
Press Releases
Gulf Pharmaceutical Industries 'Julphar' reports financial results for H1 2023
2023-08-11
· Julphar reports AED859.4 million in H1 2023, 2.5% increase year-on-year (+4.7% at constant currency), with solid growth development in UAE and across GCC region. · Over 86 million units…
Gulf Pharmaceutical Industries 'Julphar' Signs Landmark Agreement with Sunshine Lake Pharma to Pioneer Insulin Biosimilar Manufacturing in MENA
2023-05-18
Julphar is set to become the first company to localize Insulin Biosimilars manufacturing in the MENA region. The agreement includes licensing and technology transfer for Insulin Glargine and Insulin Aspart…
.jpg)
Gulf Pharmaceutical Industries Julphar reports financial results for Q1 2023
2023-05-15
Julphar reports 8.5% increase in sales compared to Q1 2022 EBITDA reaches 10% of Net Sales in Q1 2023 May 2023, Ras Al Khaimah, UAE: Gulf Pharmaceutical Industries PJSC (Julphar), one of the largest…
Julphar reports double digit revenue growth for 2022
2023-03-22
Julphar reports revenue of AED1,616 million in 2022, a 41.4 percent growth year on year Julphar’s market share growth remains key revenue driver 2030 growth strategy on track MARCH…